Citi Pharma posts flat 9MFY25 profit at nearly Rs680m

MG News | April 30, 2025 at 04:46 PM GMT+05:00
April 30, 2025 (MLN): Citi Pharma Ltd. (PSX: CPHL) reported a net profit of Rs678.84 million for the nine months ended March 31, 2025, nearly unchanged from Rs681.40m in SPLY, reflecting a flat performance despite a decline in pre-tax earnings.
Earnings per share stood at Rs2.97, slightly down from Rs2.98 a year ago.
The company’s net sales rose 6% to Rs10.10 billion from Rs9.54bn, driven by increased demand and operational scale.
Cost of sales grew proportionately by 6% to Rs8.64bn, keeping gross profit growth at 8%, amounting to Rs1.46bn.
However, operating profit also rose 8% to Rs1.17bn despite higher selling expenses, which surged 19% to Rs119.70m.
Citi Pharma’s financial cost increased 15% to Rs231.51m, while other income sharply declined by 47% to Rs165.82m, reducing support to the bottom line. As a result, profit before income taxes and final tax fell by 8% to Rs1.03bn.
Taxation decreased by 20% year-on-year to Rs349.84m, helping offset some of the pressure on net profit.
Condensed interim statement of profit and loss for the nine month ended 31 March 2025 (in Rupees) | 2025 | 2024 | %Change |
Sales - Net | 10,100,185,059 | 9,535,266,706 | 6% |
Cost of Sales | (8,643,865,934) | (8,192,103,683) | 6% |
Gross Profit | 1,456,319,125 | 1,343,163,023 | 8% |
Administrative Expenses | 161,904,092 | 154,757,727 | 5% |
Selling Expenses | 119,703,970 | 100,497,146 | 19% |
Operating Profit | 1,174,711,063 | 1,087,908,150 | 8% |
Financial (Cost) / Income | (231,505,104) | (200,800,962) | 15% |
Other Income/(Loss) | 165,818,206 | 312,952,864 | -47% |
Other Expenses | (80,335,099) | (82,062,737) | -2% |
Profit before income taxes and final tax | 1,028,689,066 | 1,117,997,315 | -8% |
Taxation - Final taxes | (4,004) | (255,970) | -98% |
Profit before income tax | 1,028,685,062 | 1,117,741,345 | -8% |
Taxation - Income tax | (349,842,286) | (436,344,074) | -20% |
Profit after income tax | 678,842,776 | 681,397,271 | 0% |
Earnings per share (EPS) - Basic and Diluted | 2.97 | 2.98 |
Copyright Mettis Link News
Related News
Name | Price/Vol | %Chg/NChg |
---|---|---|
KSE100 | 134,299.77 290.06M |
0.39% 517.42 |
ALLSHR | 84,018.16 764.12M |
0.48% 402.35 |
KSE30 | 40,814.29 132.59M |
0.33% 132.52 |
KMI30 | 192,589.16 116.24M |
0.49% 948.28 |
KMIALLSHR | 56,072.25 387.69M |
0.32% 180.74 |
BKTi | 36,971.75 19.46M |
-0.05% -16.94 |
OGTi | 28,240.28 6.19M |
0.21% 58.78 |
Symbol | Bid/Ask | High/Low |
---|
Name | Last | High/Low | Chg/%Chg |
---|---|---|---|
BITCOIN FUTURES | 118,140.00 | 119,450.00 115,635.00 |
4270.00 3.75% |
BRENT CRUDE | 70.63 | 70.71 68.55 |
1.99 2.90% |
RICHARDS BAY COAL MONTHLY | 97.50 | 0.00 0.00 |
1.10 1.14% |
ROTTERDAM COAL MONTHLY | 108.75 | 108.75 108.75 |
0.40 0.37% |
USD RBD PALM OLEIN | 998.50 | 998.50 998.50 |
0.00 0.00% |
CRUDE OIL - WTI | 68.75 | 68.77 66.50 |
2.18 3.27% |
SUGAR #11 WORLD | 16.56 | 16.60 16.20 |
0.30 1.85% |
Chart of the Day
Latest News
Top 5 things to watch in this week
Pakistan Stock Movers
Name | Last | Chg/%Chg |
---|
Name | Last | Chg/%Chg |
---|